The serum concentration of hyaluronan
Hyaluronan (HA) is one class of glycosaminoglycan (GAG) found ubiquitously in connective tissue. Metabolic studies reveal that HA enters the blood via the lymph vessels and is rapidly eliminated by the endothelial cells of the liver (Fraser et al., 1981 Smedsrod et al., 1984 . Therefore, the serum concentration of HA could be an indicator of HA overproduction in connective tissue and of impairment of its catabolism in the liver (Engstrom-Laurent et al., 1985) . A recently developed radiometric assay for HA has remarkably improved the sensitivity of the assay, making it possible to investigate the serum concentration of HA in pathological states (Tengblad, 1980) . By means of this technique, Engstrom-Laurent et al. found an increase in serum HA in patients with rheumatoid arthritis (RA) which seems to be due to enhanced production of HA in inflamatory joints (Engstrom-Laurent et al., 1987) .
The accumulation of GAG including HA in affected loci is a major pathological change in pretibial myxedema (PTM) and Graves' ophthalmopathy (GO) (Smith, T. J. et al., 1989) . We therefore investigated whether the accumulation is associated with the increase in the serum HA concentration or not in patients with PTM and GO. 
Discussion
It is an interesting question whether abnormal accumulation of HA in the skin or retroorbital tissue in a patient with Graves' dermopathy or ophthalmopathy can influence its serum concentration or not. But it has long been difficult to answer this question because of the low sensitivity of the assay method. There were trial HA measurements in serum and urine by colorimetric assay (Winand R. J., 1968) . But the results obtained were not reliable for two reasons. First, the colorimetry itself is not very accurate. Second, the low sensitivity of the colorimetry required multiple step concentrations of samples. The radiometric assay we have employed for the study is the first commercial kit which enables direct measurement of the serum HA with outstanding accuracy (Engstrom-Laurent et al., 1985) .
The results obtained in the present experiments indicate that the local accumulation of GAG including HA in PTM and GO does not increase the serum HA concentration.
A possible explanation for our results is that the amount of HA overproduction in localized skin or retroorbital tissue may not be enough to influence the serum HA concentration compared with that in systemic joints involved in RA. Another possibility is that impaired removal of HA to systemic circulation may play an important part in the accumulation of HA rather than enhanced production may do.
As this radiometric assay is specific for HA, our results do not exclude the possibility that other classes of GAG such as chondroitin sulfate or heparan sulfate may increase in the patient's serum without increasing the serum HA. But this possibility may be denied in view of the evidences that the histochemical studies showed the accumulation of HA as well as sulfated GAG in PTM and GO (Smith T. J., 1989 ). And we also disclosed that fibroblasts obtained from GO patients produced 2.9 times more HA in culture than those obtained from patients with orbital trauma (Imai et al., 1990) .
Our result also indicates that thyrotoxicosis appeared to produce no significant change in the serum HA concentration.
There still exists the possibility that the serum HA concentration of an individual patient undergoes a slight change according to his thyroid, skin, or eye state when examined longitudinally.
This aspect is now being studied in our laboratory.
